Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Duloxetine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Duloxetine 20mg gastro-resistant capsules
0704020AAAAAAAA
|
Duloxetine hydrochloride | Duloxetine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 49,194 |
|
Duloxetine 40mg gastro-resistant capsules
0704020AAAAABAB
|
Duloxetine hydrochloride | Duloxetine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 35,267 |
|
Duloxetine 30mg/5ml oral suspension
0704020AAAAAFAF
|
Duloxetine hydrochloride | Duloxetine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 54 |
|
Duloxetine 60mg/5ml oral suspension
0704020AAAAAEAE
|
Duloxetine hydrochloride | Duloxetine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.